- The Group
- Financial information
Medasys has been supporting the performance, quality and innovation of private and public healthcare institutions for almost 30 years, providing them with proven solutions in the Patient Records, care provision, Biology and Medical Imaging departments. Compliant with market standards and holding ISO 13485 and EC certification, our solutions help to optimise clinical processes to improve patient safety and the economic performance of facilities enabling them to reduce costs.
Medasys is the leading French editor of clinical solutions and holds more than a 43% share of the market in the large University Hospital/Regional Hospital segment (source IDC 2010). Providing operational solutions to more than 120 facilities and 450 public and private laboratories, Medasys has proven the quality of its solutions. Over 200,000 users connect daily to our 24hr, 7-days-a-week customer service to receive advice from highly qualified experts.
The integrated approach offered by Medasys promotes the coherence, reliability and security of patient data. Every DxCare® suite module provides different healthcare professionals (IMD, pharmacists, surgeons, nurses, secretaries, experts, radiographers, biologists, and others) within an institution with tools adapted to the management of their daily tasks whilst sharing patient data.
Medasys invests in European research projects and actively contributes to the IHE Connectathon, thus validating its solutions using established standards (HL7, DICOM, HTML, XML).
Medasys employs 230 staff and has offices in France (Clamart and Lyon), Belgium, Japan, Algeria and Morocco.
Medasys is listed in Eurolist Paris Compartment C (symbol MED - ISIN code FR 0000052623). Since June 2016, Medasys is part of the Dedalus Group, leader in the healthcare software department in Italy and a majority shareholder of NoemaLife which owns 58% of Medasys capital. With more than 1,700 employees worldwide and a presence in 25 countries, the Group, beyond its leading position in Italy, is thanks to its subsidiaries an uncontested operator in France and a significant player in Spain, the United Kingdom, the United States, Latin America, China, the Middle East and Africa.
Medasys is a member of GICAT (French Land Defence Manufacturers Association).
Finally, Medasys received new ISO 14001 v2004 certification on 21 December 2012.